Injecto Polymers Other Announcement
Injecto Polymers filed the first monitoring agency report on its IPO proceeds for the quarter ended 30 September 2026. The report states no deviation from the stated objects.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements
Injecto Polymers filed the first monitoring agency report on its IPO proceeds for the quarter ended 30 September 2026. The report states no deviation from the stated objects.
Injecto Polymers Ltd reported revenue from operations of ₹193.5 Cr (+34.5% YoY) and net profit of ₹10.7 Cr (+94.5% YoY) for H1 FY27.
Injecto Polymers Ltd has scheduled a board meeting for November 11, 2026. The board will consider half-yearly unaudited financial results and IPO proceeds utilization.
Injecto Polymers Limited submitted its quarterly statement of investor grievances for the period ended 30th September 2026, reporting nil pending complaints.
Injecto Polymers Ltd filed its quarterly shareholding pattern under Regulation 31. This is a routine compliance disclosure for shareholders.
CapitalSquare Financial Services, a market maker, bought 958,800 Injecto Polymers shares (4.61%) on the open market, raising its stake to 5.97%. No transaction price was disclosed.